T
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
Price:
15.98
TRY
1.78%
Market Cap:
₺2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
|
TR |
|
Fortune Brands Innovations Inc
NYSE:FBIN
|
US |
|
STO Express Co Ltd
SZSE:002468
|
CN |
|
Recon Technology Ltd
NASDAQ:RCON
|
CN |
Multiples-Based Value
The Multiples-Based Value of one TRILC.E stock under the Base Case scenario is hidden TRY. Compared to the current market price of 15.98 TRY, Turk Ilac ve Serum Sanayi AS is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRILC.E Multiples-Based Value
LOCKED
Multiples Across Competitors
TRILC.E Competitors Multiples
Turk Ilac ve Serum Sanayi AS Competitors
Turk Ilac ve Serum Sanayi AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TR |
T
|
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
|
2.6B TRY | 0.6 | -4.2 | 3.7 | 3.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.6 | 43 | 29 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP | 5.3 | 30.3 | 16.7 | 23.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.5 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118B USD | 2.5 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
